ARTICLE | Distillery Therapeutics
Inhibiting NR4A1, NR4A2 and N4RA3 in CAR Ts to enhance efficacy in solid tumors
March 5, 2019 10:36 PM UTC
INDICATION: Melanoma; colorectal cancer ...
BCIQ Company Profiles
INDICATION: Melanoma; colorectal cancer ...
BCIQ Company Profiles
BCIQ Company Profiles